Clinical Trial Update: Micellar Paclitaxel to Treat Severe Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating micellar paclitaxel for severe psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Micellar Paclitaxel (paclitaxel (micellar formulation))

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Psoriasis | Phase 2 | Status: COMPLETED